Category Archives: Proton Pump Inhibitors

Featured Stories
Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

MTA Bus Crash and Two Cars Injures 23 at Utica Ave. & Clarendon Rd

Crash Involving MTA Bus and Two Cars Injures 23

Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.

Read More

Proton Pump Inhibitors Raise Infection Risk in Cirrhosis Patients

Proton Pump Inhibitors (PPIs) such as Prilosec, Aciphex, Prevacid, and Protonix, raise infection risks in cirrhosis patients, according to a new study that found the risk for serious infections affects patients with decompensated cirrhosis. PPI users suffer from a 66 … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Meta-Analysis Finds Proton Pump Inhibitors Increase Risk of C. Difficile-Associated Diarrhea by 69%

A newly-published study has again shown that the use of popular heartburn drugs known as proton pump inhibitors can increase the likelihood that a person will develop Clostridium difficile-associated diarrhea.  The authors of the study, which appears in the American … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Study Finds “Robust” Risk of C. difficile with Proton Pump Inhibitors, other Heartburn Drugs

A new study has found that taking acid reducing drugs, including proton pump inhibitors, can significantly increase the risk for Clostridium difficile (C. difficile) infection. The lead author of the study, which involved a meta-analysis of 30 separate studies, characterized … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

PPI Side Effect Warnings for Fractures, Hypomagnesaemia Issued in U.K.

U.K. regulators issued two warnings this week regarding serious Proton Pump Inhibitor (PPI) side effects. According to the Medical and Healthcare Products Regulatory Agency (MHRA), recent studies indicated a link between long-term use of PPIs and fractures of the hip, … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Health Canada Warns PPIs May Cause C. Diff-Associated Diarrhea

Health Canada is warning Canadians that prescription stomach antacids called proton pump inhibitors (PPIs) may cause Clostridium difficile–associated diarrhea (CDAD). CDAD is a potentially serious gastrointestinal infection. C. diff is bacterium that can cause diarrhea and may lead to more … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

FDA Says Proton Pump Inhibitors May Cause C-difficile Diarrhea

Using popular heartburn drugs called proton pump inhibitors (PPIs) could put some users at risk of contracting Clostridium difficile–associated diarrhea (CDAD), a potentially serious gastrointestinal infection. In a Drug Safety Communication issued yesterday, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Another Study Links Popular Heartburn Drugs to Hip Fractures

A new study is providing more evidence of an association between hip fractures in older women and the use of popular heartburn drugs known as proton pump inhibitors (PPIs). The study, published in the British Medical Journal, found that post-menopausal … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Proton Pump Inhibitors Linked to Heart Birth Defects

Proton Pump Inhibitors (PPIs) have been being linked to heart birth defects, when taken by women in the first trimester of pregnancy, according to a recent study. Popular PPIs include Aciphex (rabeprazole), Nexium (esomeprazole), Prevacid (lansoprazole), Prilosec (omeprazole), and Protonix … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Studies Show Many People Taking Proton Pump Inhibitors Don’t Need Them

Aciphex, Dexilant, Nexium, Prevacid, Prilosec, and Protonix, all part of a class of drugs known a < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">proton pump inhibitors, may be overprescribed, some recent studies indicate. According to a report from Web MD, overuse of proton pump inhibitors, which … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

New Study Finds PPIs Increase Risk For C. Diff

Popular heartburn medications, < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">Proton Pump Inhibitors (PPIs), have been linked to more adverse reactions; this time, Clostridium difficile (C. diff), in a large Japanese study presented at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy. We recently wrote … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.